FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 321:857-862 September 28, 1989 Number 13 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We compared two procedures for the emergency treatment of bleeding esophageal varices in patients who did not respond to blood transfusion and vasoactive drugs. We randomly assigned 101 patients with cirrhosis of the liver and bleeding esophageal varices to undergo either emergency sclerotherapy (n = 50) or staple transection of the esophagus (n = 51). Four patients assigned to sclerotherapy and 12 assigned to staple transection did not actually undergo those procedures, but all analyses were made on an intention-to-treat basis. Total mortality did not differ significantly between the two groups; the relative risk of death for staple transection as compared with sclerotherapy was 0.88 (95 percent confidence interval, 0.51 to 1.54). Mortality at six weeks was 44 percent among those assigned to sclerotherapy and 35 percent among those assigned to staple transection. Complication rates were similar for the two groups. An interval of five days without bleeding was achieved in 88 percent of those assigned to staple transection and in 62 percent of those assigned to sclerotherapy after a single injection (P less than 0.01) and 82 percent after three injections. In only 2 of the 11 patients who received a third sclerotherapy injection was bleeding controlled for more than five days, and 9 died. We conclude that staple transection of the esophagus is as safe as sclerotherapy for the emergency treatment of bleeding esophageal varices and that it is more effective than a single sclerotherapy procedure. We currently recommend surgery after two injection treatments have failed.

Source Information

Hepato-biliary and Liver Transplantation Unit, Royal Free Hospital, London, United Kingdom.

This article has been cited by other articles:

• Samonakis, D N, Triantos, C K, Thalheimer, U, Patch, D W, Burroughs, A K (2004). Management of portal hypertension. Postgrad. Med. J. 80: 634-641 [Abstract] [Full Text]  
• Sharara, A. I., Rockey, D. C. (2001). Gastroesophageal Variceal Hemorrhage. NEJM 345: 669-681 [Full Text]  
• Jalan, R, Hayes, P C (2000). UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 46: iii1-15 [Full Text]  
• JALAN, R, LUI, H F, REDHEAD, D N, HAYES, P C (2000). TIPSS 10 years on. Gut 46: 578-581 [Full Text]  
• Besson, I., Ingrand, P., Person, B., Boutroux, D., Heresbach, D., Bernard, P., Hochain, P., Larricq, J., Gourlaouen, A., Ribard, D., Kara, N. M., Legoux, J.-L., Pillegand, B., Becker, M.-C., Di Costanzo, J., Metreau, J.-M., Silvain, C., Beauchant, M. (1995). Sclerotherapy with or without Octreotide for Acute Variceal Bleeding. NEJM 333: 555-560 [Abstract] [Full Text]  
• Grace, N. D. (1994). The Side-to-Side Portacaval Shunt Revisited. NEJM 330: 208-209 [Full Text]  
• Spence, R. K. (1993). Transfusion Practices in Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER 6: 14-43